Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
WS01 - IASLC Reviewer Workshop (By Invitation Only)
- 09:00 - 15:20
- 8/05/2022
- Location: Lehar 1
- Not for CME Credit
- Type: Workshop
- Track: N/A
- Moderators:Alex Adjei
-
+
Session Moderator
09:00 - 09:00 | Presenter: Alex Adjei
- Abstract
Loading... -
+
WS01.01 - Session Introduction
09:00 - 09:10 | Presenter: Alex Adjei
- Abstract
Loading... -
+
WS01.02 - Technical Aspects of Editorial Manager
09:10 - 09:25 | Presenter: Mary Todd
- Abstract
Loading... -
+
WS01.03 - Publishing Ethics
09:25 - 09:40 | Presenter: Vun-Sin Lim
- Abstract
Loading... -
+
WS01.04 - Abstract, Introduction
09:40 - 09:55 | Presenter: ENRIQUETA FELIP
- Abstract
Loading... -
+
WS01.05 - Break
09:55 - 10:05
- Abstract
Loading... -
+
WS01.06 - Methods
10:05 - 10:20 | Presenter: Anne-Marie Baird
- Abstract
Loading... -
+
WS01.07 - Results, Discussion
10:20 - 10:35 | Presenter: Jean-Louis Pujol
- Abstract
Loading... -
+
WS01.08 - Impact
10:35 - 10:50 | Presenter: Alex Adjei
- Abstract
Loading... -
+
WS01.09 - Break
10:50 - 11:00
- Abstract
Loading... -
+
WS01.10 - Participant Presentation: Article 3 Review by Haval Balata, Jules Derks, Francesca Jacobs, Laura Moliner, Filiz Oezkan
11:00 - 11:25
- Abstract
Loading... -
+
WS01.10 - Article 3 Summary + Group Discussion
11:25 - 11:55 | Presenter: Jean-Louis Pujol
- Abstract
Loading... -
+
WS01.11 - Lunch
11:55 - 12:55
- Abstract
Loading... -
+
WS01.12 - Participant Presentation: Article 2 Review by Samina Park, Periklis Perikeleous, Anne Marie Quinn, Pedro Rocha, Seyer Safi
12:55 - 13:20
- Abstract
Loading... -
+
WS01.13 - Article 2 Summary + Group Discussion
13:20 - 13:50 | Presenter: Anne-Marie Baird
- Abstract
Loading... -
+
WS01.14 - Break
13:50 - 14:00
- Abstract
Loading... -
+
WS01.15 - Participant Presentation: Article 1 Review by Martin Barr, Maristella Bungaro, Jo Raskin, Maria Lucia Reale, Tiziana Vavala, Gerard Walls
14:00 - 14:30
- Abstract
Loading... -
+
WS01.16 - Article 1 Summary + Group Discussion
14:30 - 15:00 | Presenter: ENRIQUETA FELIP
- Abstract
Loading... -
+
WS01.17 - Further Q&A
15:00 - 15:15
- Abstract
Loading... -
+
WS01.18 - Group Photo
15:15 - 15:20
- Abstract
Loading...
-
+
WS03 - Early Career & First Time Attendee Session
- 08:00 - 11:30
- 8/06/2022
- Location: Lehar 1
- Not for CME Credit
- Type: Workshop
- Track: N/A
- Moderators:Karen Kelly, Heather Wakelee
-
+
WS03.09 - Principles to Get Your Paper Published
09:51 - 10:06 | Presenter: Alex Adjei
- Abstract
Loading...
-
+
EP05.01 - Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
-
+
EP05.01-011 - Real World Outcomes of Durvalumab after Chemoradiotherapy in unresectable advanced Non-Small Cell Lung Cancer: The Mayo Clinic Experience.
Presenter: Joel Rivera Concepcion- Abstract
Loading...
-
+
EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
-
+
EP08.01-028 - Overestimation with Cox HR - Cox-TEL-Adjusted Associations of PD-L1 Expression with Immune Checkpoint Inhibitor Survival Benefit in Lung Cancer
Presenter: Emily Pei-Ying Lin- Abstract
Loading...
-
+
MA13 - Update on ROS1 Inhibitors and New Pathways
- 12:00 - 13:00
- 8/09/2022
- Location: Hall C7
- Not for CME Credit
- Type: Mini Oral
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Moderators:Lorenza Landi, Jii Bum (Joy) Lee
-
+
MA13.09 - Time from Immune Checkpoint Inhibitor to Sotorasib Use Correlates with Risk of Hepatotoxicity in Non-small Cell Lung Cancer
12:37 - 12:42 | Presenter: Sagar Rakshit
- Abstract
Loading...
